HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Supplement Market Growth: Is The Industry In Its Own Way?

This article was originally published in The Rose Sheet

Executive Summary

Longtime supplement industry attorney Scott Bass says supplement manufacturers should work with FDA as an ally, including registering products with the agency pre-market, while FDA's second-in-command for supplement industry oversight, Robert Durkin, says the agency is not interested in preventing more safe products from reaching the market.

Advertisement

Related Content

Bodybuilding.com Hoists Its Regulatory Experience As Lesson For Compliance
Supplement GMP Inspections Slowing As FDA Makes 'Potential' Data Useful
Industry Eyes NDI Notification Common Ground With Gottlieb-Led FDA
FDA Dietary Supplement Division Soon May Need Office Accommodations
Supplement GMPs Stress Responsibility, Put Firms In Driver’s Seat For Testing

Topics

Advertisement
UsernamePublicRestriction

Register

RS121674

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel